Revista da Sociedade Brasileira de Medicina Tropical · 2016
Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Duque Maria Cristina de Oliveira, Vasconcellos Érica de Camargo Ferreira E, Pimentel Maria Inês Fernandes, Lyra Marcelo Rosandiski, Pacheco Sandro Javier Bedoya, Marzochi Mauro Celio de Almeida, Rosalino Cláudia Maria Valete, Schubach Armando de Oliveira
Аннотация
INTRODUCTION:: Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity.
METHODS: Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals.
RESULTS: The technique is described in detail sufficient to enable replication.
CONCLUSIONS:: The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.
METHODS: Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals.
RESULTS: The technique is described in detail sufficient to enable replication.
CONCLUSIONS:: The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.